Detalles de la búsqueda
1.
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer.
Int J Mol Sci
; 24(13)2023 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37446056
2.
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer.
bioRxiv
; 2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36798357
Resultados
1 -
2
de 2
1
Próxima >
>>